Q2 2021

Source filing unavailable

Q2 2021 · —

Revenue

$6.06M

+50.4% vs Q2 2020

Net Income

-$3.20M

N/M vs Q2 2020

EPS Diluted

-$0.12

no prior Q2 2020 on file

Gross Profit$2,361,000+94.0%

Operating Income-$2,895,000N/M

Operating Cash Flow-$985,000

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	$6.06M	$4.03M	$20.75M	$1.03M
Net Income	-$3.20M	-$3.10M	$12.72M	-$4.17M
EPS Diluted	-$0.12	—	—	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

MediWound Ltd. · CIK 1593984 · Engraved from SEC EDGAR